People · Operator
Named in public records as an officer, director or promoter · active 2013–2024 · Biotechnology, Other, Other Health Care, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Delphinus Medical Technologies, Inc. | — | Biotechnology | Series B | $117.9M | $221.5M | 2017 |
| BioIQ, Inc. | — | Other | Series B | $59.6M | $232.6M | 2019 |
| Wellfount, Corp | — | Other Health Care | Series A | $49.4M | $240.5M | 2015 |
| ArborMetrix, Inc. | — | Other Health Care | Series A | $31.2M | $38.4M | 2013 |
| ADVANCE Medical, Ltd. | — | Other | Series B | $19.8M | $328.1M | 2013 |
| NAVV Systems, Inc. | — | Software / Tech | Series A | $9.7M | $9.7M | 2024 |
Paul McCreadie at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Paul McCreadie on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Timothy Petersen | 2 | 9 |
| Maria Siambekos | 2 | 2 |
| Bryan Roberts | 1 | 18 |
| Michael Gross | 1 | 9 |
| Scott White | 1 | 7 |
| Jim Smith | 1 | 6 |
| Andrew Midler | 1 | 6 |
| Todd Creech | 1 | 4 |
| Brandon Cady | 1 | 4 |
| Mark McClellan | 1 | 3 |
| Darren Hite | 1 | 3 |
| Fred Aslan | 1 | 3 |
| Brent Peus | 1 | 3 |
| John Neis | 1 | 3 |
| Tadd Miller | 1 | 2 |
| Anthony Grover | 1 | 2 |
| Patrick Cua | 1 | 2 |
| Paul J. McCreadie | 1 | 2 |
| Timothy Peterson | 1 | 2 |
| Mark J. Forchette | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.